Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

50Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Artemisinins are plant products with a wide range of medicinal applications. Most prominently, artesunate is a well tolerated and effective drug for treating malaria, but is also active against several protozoal and schistosomal infections, and additionally exhibits anti-angiogenic, anti-tumorigenic and anti-viral properties. The array of activities of the artemisinins, and the recent emergence of malaria resistance to artesunate, prompted us to synthesize and evaluate several novel artemisinin-like derivatives. Sixteen distinct derivatives were therefore synthesized and thein vitrocytotoxic effects of each were tested with different cell lines. Thein vivoanti-angiogenic properties were evaluated using a zebrafish embryo model. We herein report the identification of several novel artemisinin-like compounds that are easily synthesized, stable at room temperature, may overcome drug-resistance pathways and are more activein vitroandin vivothan the commonly used artesunate. These promising findings raise the hopes of identifying safer and more effective strategies to treat a range of infections and cancer. © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Soomro, S., Langenberg, T., Mahringer, A., Konkimalla, V. B., Horwedel, C., Holenya, P., … Efferth, T. (2011). Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties. Journal of Cellular and Molecular Medicine, 15(5), 1122–1135. https://doi.org/10.1111/j.1582-4934.2010.01120.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free